2-[2-(4-Fluorophenyl)pyrazolo[1,5-a]pyridin-5-yl]benzaldehyde → 1-{2-[2-(4-Fluorophenyl)pyrazolo[1,5-a]pyridin-5-yl]phenyl}prop-2-yn-1-ol
反応式
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:24]=[C:11]3[CH:12]=[C:13]([C:16]4[CH:23]=[CH:22][CH:21]=[CH:20][C:17]=4[CH:18]=[O:19])[CH:14]=[CH:15][N:10]3[N:9]=2)=[CH:4][CH:3]=1.[C:25]([Mg]Br)#[CH:26]>O1CCCC1>[F:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[CH:24]=[C:11]3[CH:12]=[C:13]([C:16]4[CH:23]=[CH:22][CH:21]=[CH:20][C:17]=4[CH:18]([OH:19])[C:25]#[CH:26])[CH:14]=[CH:15][N:10]3[N:9]=2)=[CH:6][CH:7]=1参加物
4
実験手順
The procedure described in stage 2.5 is followed, starting with 0.245 g (0.77 mmol) of 2-[2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-5-yl]benzaldehyde obtained in stage 5.1, in solution in 15 ml of tetrahydrofuran, followed by addition of 4.65 ml (2.32 mmol) of an ethynylmagnesium bromide solution (0.5M in tetrahydrofuran) and after chromatography on silica gel, elution being carried out with dichloromethane, 0.08 g (30%) of the expected product is obtained in the form of a pale yellow powder.